Thought of the Week: What We Give
July 17, 2025
Thought of the Week: More Cherished
Related:
Thought of the Week: Dissolving the Pain
July 9, 2025
Thought of the Week: What I Can Do
July 1, 2025
Thought of the Week – Kindness Grows Abundant
June 17, 2025
As I Grow Older
June 11, 2025
Honoring Dad on Father’s Day
June 10, 2025
Email me when people comment
Login
0 Comments
Edited by:
Peter Berger
With experience in dementia caregiving, public education, and Alzheimer’s-focused writing—and a professional research background shaped in what many consider one of the world’s top laboratories—I work to make complex findings clear, practical, and genuinely helpful for families and professionals providing care.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Prevention
Does Dementia Risk Depend on Where You Live?
See one of the largest and most comprehensive studies identifying where dementia occurs most often.
No Comments
Breakthrough
FDA Approves Aduhelm, New Alzheimer’s Drug
BREAKTHROUGH: FOR THE FIRST TIME in 18 years, the FDA approved a new Alzheimer’s drug. The new medication’s generic name is aducanumab and will be marketed under the brand name Aduhelm. Another first is the drug’s ability to potentially slow down Alzheimer’s, not just cover up its symptoms, as existing medications do. Find out more.
No Comments
Drugs:Behavior
Prevent Falls in Parkinson’s with Rivastigmine for Dementia
People with Parkinson’s were given the oral drug rivastigmine (brand name Exelon®). They were 45% less likely to fall and were considerably steadier when walking. Learn more about this dementia drug and fall prevention.
No Comments
Caregiving
The ABC’s of Alzheimer’s, Bladders and Cholinesterase Inhibitors
Researchers in Houston, Texas find that taking a cholinesterase inhibitor such as donepezil may increase one’s trips to the bathroom. Learn more.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On